Literature DB >> 17147912

Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.

Ann M Arvin1.   

Abstract

Varicella zoster virus (VZV) is a medically important human herpesvirus that causes varicella, establishes latency in sensory ganglia and may reactivate to cause herpes zoster in healthy and immunocompromised patients. Experiments in the severe combined immunodeficiency (SCID) mouse model have provided new insights about VZV pathogenesis. In addition, the evaluation of VZV recombinant viruses, with targeted mutations of viral genes or their promoters in SCIDhu skin, T-cell and dorsal root ganglia xenografts, has the potential to identify options for the design of a recombinant 'second-generation' VZV vaccine. This would be characterized by the retention of infectivity in skin combined with a restricted tropism for T-cells and neurons within sensory ganglia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17147912

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  12 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Calculation of the anterograde velocity of varicella-zoster virions in a human sciatic nerve during shingles.

Authors:  Raymond Tannous; Charles Grose
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

3.  ORF7 of varicella-zoster virus is a neurotropic factor.

Authors:  Anca Selariu; Tong Cheng; Qiyi Tang; Benjamin Silver; Lianwei Yang; Che Liu; Xiangzhong Ye; Amos Markus; Ronald S Goldstein; Ruth S Cruz-Cosme; Yanzhen Lin; Lanling Wen; Hongliu Qian; Jinle Han; Kalpana Dulal; Ying Huang; Yimin Li; Ningshao Xia; Hua Zhu
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

4.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

5.  Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.

Authors:  Sylvie François; Nandini Sen; Bryan Mitton; Xiangshu Xiao; Kathleen M Sakamoto; Ann Arvin
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

6.  A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.

Authors:  B Karsten Tischer; Benedikt B Kaufer; Marvin Sommer; Felix Wussow; Ann M Arvin; Nikolaus Osterrieder
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.

Authors:  Geoffrey A Peters; Shaun D Tyler; John E Carpenter; Wallen Jackson; Yasuko Mori; Ann M Arvin; Charles Grose
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

8.  A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Authors:  Moriah L Szpara; Yolanda R Tafuri; Lance Parsons; S Rafi Shamim; Kevin J Verstrepen; Matthieu Legendre; L W Enquist
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

9.  Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.

Authors:  Li Wang; Stefan L Oliver; Marvin Sommer; Jaya Rajamani; Mike Reichelt; Ann M Arvin
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

10.  Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 Expression.

Authors:  Keith W Jarosinski; John E Carpenter; Erin M Buckingham; Wallen Jackson; Kevin Knudtson; Jennifer F Moffat; Hirohito Kita; Charles Grose
Journal:  Open Forum Infect Dis       Date:  2018-05-22       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.